Partner Roger Strode was quoted in a Chicago Tribune article, “Hospira Stock Soars as Pfizer Says it will Buy for $15.23 Billion,” on February 5, 2015. The article discussed details surrounding pharmaceutical giant Pfizer’s plans to buy Illinois drug maker Hospira. Strode was quoted saying, “The shareholders of Hospira are going to be really well off. Hospira’s stock has zoomed already. It’s a huge benefit to them.”
Strode also touched on the outlook for mergers and acquisitions in the pharmaceutical industry and said, “Pharma has been very robust. A lot of companies have done well and they’re sitting on a lot of cash. We’re still in the middle of a bull market.”
Strode also touched on the outlook for mergers and acquisitions in the pharmaceutical industry and said, “Pharma has been very robust. A lot of companies have done well and they’re sitting on a lot of cash. We’re still in the middle of a bull market.”
People
Related News
23 January 2025
In the News
Claude Treece Featured as Longtime Champion of Foley's MLK Jr. Oratory Competition
Foley & Lardner LLP partner Claude Treece is featured for his decades-long leadership of the firm's annual Martin Luther King Jr. Oratory Competition.
22 January 2025
In the News
Nathan Beaver and Marika Miller Quoted on DEA Proposal on Special Registration for Telemedicine
Foley & Lardner LLP attorneys Nathan Beaver and Marika Miller are quoted in the healthleaders article, "Prescribing Pullback: Telehealth Advocates Ask Trump to Withdraw DEA Proposal."
21 January 2025
In the News
Foley’s 2025 MLK Jr. Oratory Competition Garners Significant Media Coverage
Foley & Lardner LLP’s 2025 Martin Luther King Jr. Oratory Competition garnered significant media attention this year as the student's message of leadership, unity, and civic responsibility especially resonated as the day celebrating Dr. King’s legacy coincided with the U.S. Presidential Inauguration.